Multiple functional polymorphisms in the G6PC2 gene contribute to the association with higher fasting plasma glucose levels

Diabetologia

Volumn 56, Issue 6, 2013, Pages 1306-1316

  Baerenwald, D A ^a   Bonnefond, A ^b,c   Bouatia Naji, N ^b,c,d   Flemming, B P ^a   Umunakwe, O C ^a   Oeser, J K ^a   Pound, L D ^a   Conley, N L ^a   Cauchi, S ^b,c   Lobbens, S ^b,c   Eury, E ^b,c   Balkau, B ^e,f   Lantieri, O ^g   Dadi, P K ^a   Jacobson, D A ^a   Froguel, P ^a,b,c,h   O'Brien, R M ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INSTITUT PASTEUR DE LILLE   (France)

^c UNIV LILLE   (France)

^d PARIS CARDIOVASCULAR RESEARCH CENTER   (France)

^e CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

^f UNIVERSITÉ PARIS SACLAY   (France)

^g Institut Inter Regional Pour la Santé IRSA   (France)

^h IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Beta cell; Fasting plasma glucose; G6PC2 IGRP; Pancreatic islet; Splicing; Transcription

Indexed keywords

GLUCOSE; HEPATOCYTE NUCLEAR FACTOR 3BETA;

ARTICLE; FEMALE; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; GLUCOSE 6 PHOSPHATASE CATALYTIC SUBUNIT GENE 2; GLUCOSE BLOOD LEVEL; HUMAN; INTRON; MALE; PRIORITY JOURNAL; PROMOTER REGION; QUANTITATIVE TRAIT; RNA SPLICING; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; BLOOD GLUCOSE; DIABETES MELLITUS; FASTING; FEMALE; GENE EXPRESSION REGULATION; GENOTYPE; GLUCOSE-6-PHOSPHATASE; HELA CELLS; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RNA SPLICING; RNA, MESSENGER;

EID: 84877742778     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-013-2875-3     Document Type: Article

References (50)

1. Hutton JC, O'Brien RM (2009) The glucose-6-phosphatase catalytic subunit gene family. J Biol Chem 284:29241-29245
2. Arden SD, Zahn T, Steegers S et al (1999) Molecular cloning of a pancreatic islet-specific glucose-6-phosphatase catalytic subunit-related protein. Diabetes 48:531-542
3. Martin CC, Bischof LJ, Bergman B et al (2001) Cloning and characterization of the human and rat islet-specific glucose-6-phosphatase catalytic subunit-related protein (IGRP) genes. J Biol Chem 276:25197-25207
4. Wang Y, Martin CC, Oeser JK et al (2007) Deletion of the gene encoding the islet-specific glucose-6-phosphatase catalytic subunit-related protein autoantigen results in a mild metabolic phenotype. Diabetologia 50:774-778
5. Hutton JC, Eisenbarth GS (2003) A pancreatic beta-cell-specific homolog of glucose-6-phosphatase emerges as a major target of cell-mediated autoimmunity in diabetes. Proc Natl Acad Sci U S A 100:8626-8628
6. Bouatia-Naji N, Rocheleau G, van Lommel L et al (2008) A polymorphism within the G6PC2 gene is associated with fasting plasma glucose levels. Science 320:1085-1088
7. Chen WM, Erdos MR, Jackson AU et al (2008) Variations in the G6PC2/ABCB11 genomic region are associated with fasting glucose levels. J Clin Invest 118:2620-2628
8. Droumaguet C, Balkau B, Simon D et al (2006) Use of HbA1c in predicting progression to diabetes in French men and women: data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR). Diabetes Care 29:1619-1625
9. Abdul-Ghani MA, DeFronzo RA (2009) Plasma glucose concentration and prediction of future risk of type 2 diabetes. Diabetes Care 32(Suppl 2):S194-S198
10. Edelman D, Olsen MK, Dudley TK, Harris AC, Oddone EZ (2004) Utility of hemoglobin A1c in predicting diabetes risk. J Gen Intern Med 19:1175-1180
11. Coutinho M, Gerstein HC, Wang Y, Yusuf S (1999) The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care 22:233-240
12. Khaw KT, Wareham N, Luben R et al (2001) Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European prospective investigation of cancer and nutrition (EPIC-Norfolk). BMJ 322:15-18
13. Sarwar N, Gao P, Seshasai SR et al (2010) Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 375:2215-2222
14. Prokopenko I, Langenberg C, Florez JC et al (2008) Variants in MTNR1B influence fasting glucose levels. Nat Genet 41:77-81
15. Bouatia-Naji N, Bonnefond A, Cavalcanti-Proenca C et al (2009) A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk. Nat Genet 41:89-94
16. Reiling E, van 't Riet E, Groenewoud MJ et al (2009) Combined effects of single-nucleotide polymorphisms in GCK, GCKR, G6PC2 and MTNR1B on fasting plasma glucose and type 2 diabetes risk. Diabetologia 52:1866-1870
17. Dupuis J, Langenberg C, Prokopenko I et al (2010) New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet 42:105-116
18. Hu C, Zhang R, Wang C et al (2009) A genetic variant of G6PC2 is associated with type 2 diabetes and fasting plasma glucose level in the Chinese population. Diabetologia 52:451-456
19. Newgard CB, Lu D, Jensen MV et al (2002) Stimulus/secretion coupling factors in glucose-stimulated insulin secretion: insights gained from a multidisciplinary approach. Diabetes 51(Suppl 3):S389-S393
20. Bouatia-Naji N, Bonnefond A, Baerenwald DA et al (2010) Genetic and functional assessment of the role of the rs13431652-A and rs573225-A alleles in the G6PC2 promoter that strongly associate with elevated fasting glucose levels. Diabetes 59:2662-2671
21. Voight BF, Kang HM, Ding J et al (2012) The Metabochip, a custom genotyping array for genetic studies of metabolic, cardiovascular, and anthropometric traits. PLoS Genetics 8:e1002793
22. Singh G, Cooper TA (2006) Minigene reporter for identification and analysis of cis elements and trans factors affecting pre-mRNA splicing. Biotechniques 41:177-181
23. Cooper TA (1998) Muscle-specific splicing of a heterologous exon mediated by a single muscle-specific splicing enhancer from the cardiac troponin T gene. Mol Cell Biol 18:4519-4525
24. Martin CC, Oeser JK, O'Brien RM (2004) Differential regulation of islet-specific glucose-6-phosphatase catalytic subunit-related protein gene transcription by Pax-6 and Pdx-1. J Biol Chem 279:34277-34289
25. Martin C, Flemming B, Wang Y, Oeser J, O'Brien R (2008) Foxa2 and MafA regulate islet-specific glucose-6-phosphatase catalytic subunit-related protein (IGRP/G6PC2) gene expression. J Mol Endocrinol 41:315-328
26. Dogra RS, Vaidyanathan P, Prabakar KR, Marshall KE, Hutton JC, Pugliese A (2006) Alternative splicing of G6PC2, the gene coding for the islet-specific glucose-6-phosphatase catalytic subunit-related protein (IGRP), results in differential expression in human thymus and spleen compared with pancreas. Diabetologia 49:953-957
27. Stoss O, Stoilov P, Hartmann AM, Nayler O, Stamm S (1999) The in vivo minigene approach to analyze tissue-specific splicing. Brain Res Brain Res Protoc 4:383-394
28. Cooper TA (2005) Use of minigene systems to dissect alternative splicing elements. Methods 37:331-340
29. Ebert DH, Bischof LJ, Streeper RS et al (1999) Structure and promoter activity of an islet-specific glucose-6-phosphatase catalytic subunit-related gene. Diabetes 48:543-551
30. Jackson IJ (1991) A reappraisal of non-consensus mRNA splice sites. Nucleic Acids Res 19:3795-3798
31. Bischof LJ, Martin CC, Svitek CA et al (2001) Characterization of the mouse islet-specific glucose-6-phosphatase catalytic subunit-related protein gene promoter by in situ footprinting. Correlation with fusion gene expression in the islet derived βTC-3 and hamster insulinoma tumor cell lines. Diabetes 50:502-514
32. Frigeri C, Martin CC, Svitek CA et al (2004) The proximal islet-specific glucose-6-phosphatase catalytic subunit related protein (IGRP) autoantigen promoter is sufficient to initiate but not maintain transgene expression in mouse islets in vivo. Diabetes 53:1754-1764
33. Martin CC, Oeser JK, Svitek CA, Hunter SI, Hutton JC, O'Brien RM (2002) Identification and characterization of a human cDNA and gene encoding a ubiquitously expressed glucose-6-phosphatase catalytic subunit-related protein. J Mol Endocrinol 29:205-222
34. Quandt K, Frech K, Karas H, Wingender E, Werner T (1995) MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res 23:4878-4884
35. Hannenhalli S, Kaestner KH (2009) The evolution of Fox genes and their role in development and disease. Nat Rev Genet 10:233-240
36. Friedman JR, Kaestner KH (2006) The Foxa family of transcription factors in development and metabolism. Cell Mol Life Sci 63:2317-2328
37. Overdier DG, Porcella A, Costa RH (1994) The DNA-binding specificity of the hepatocyte nuclear factor 3/forkhead domain is influenced by amino-acid residues adjacent to the recognition helix. Mol Cell Biol 14:2755-2766
38. Tuteja G, White P, Schug J, Kaestner KH (2009) Extracting transcription factor targets from ChIP-Seq data. Nucleic Acids Res 37:e113
39. Sparso T, Andersen G, Nielsen T et al (2008) The GCKR rs780094 polymorphism is associated with elevated fasting serum triacylglycerol, reduced fasting and OGTT-related insulinaemia, and reduced risk of type 2 diabetes. Diabetologia 51:70-75
40. Orho-Melander M, Melander O, Guiducci C et al (2008) Common missense variant in the glucokinase regulatory protein gene is associated with increased plasma triglyceride and C-reactive protein but lower fasting glucose concentrations. Diabetes 57:3112-3121
41. Pare G, Chasman DI, Parker AN et al (2008) Novel association of HK1 with glycated hemoglobin in a non-diabetic population: a genome-wide evaluation of 14,618 participants in the Women's Genome Health Study. PLoS Genetics 4:e1000312
42. Soranzo N, Sanna S, Wheeler E et al (2010) Common variants at ten genomic loci influence hemoglobin A1C levels via glycemic and non-glycemic pathways. Diabetes 59:3229-3239
43. Lyssenko V, Lupi R, Marchetti P et al (2007) Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes. J Clin Invest 117:2155-2163
44. Gaulton KJ, Nammo T, Pasquali L et al (2010) A map of open chromatin in human pancreatic islets. Nat Genet 42:255-259
45. Sharp PA (1994) Split genes and RNA splicing. Cell 77:805-815
46. Solis AS, Shariat N, Patton JG (2008) Splicing fidelity, enhancers, and disease. Front Biosci 13:1926-1942
47. Dos Santos C, Bougneres P, Fradin D (2009) An SNP in a methylatable Foxa2 binding site of the G6PC2 promoter is associated with insulin secretion in vivo and increased promoter activity in vitro. Diabetes 58:489-492
48. Gao N, Le Lay J, Qin W et al (2010) Foxa1 and Foxa2 maintain the metabolic and secretory features of the mature beta-cell. Mol Endocrinol 24:1594-1604
49. Taneera J, Lang S, Sharma A et al (2012) A systems genetics approach identifies genes and pathways for type 2 diabetes in human islets. Cell Metab 16:122-134
50. O'Brien RM, Noisin EL, Suwanichkul A et al (1995) Hepatic nuclear factor 3- and hormone-regulated expression of the phosphoenolpyruvate carboxykinase and insulin-like growth factor-binding protein 1 genes. Mol Cell Biol 15:1747-1758